Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
- Status
- COMPLETED
- Phase
- N/A
Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
The COMPASSION Study
- Status
- RECRUITING
- Phase
- NA
STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)
- Status
- RECRUITING
- Phase
- NA
Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
- Status
- RECRUITING
- Phase
- PHASE2
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
- Status
- RECRUITING
- Phase
- PHASE2
Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.
- Status
- RECRUITING
- Phase
- N/A
HER-2 B Cell Peptide Vaccine
- Status
- RECRUITING
- Phase
- PHASE1
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
- Status
- COMPLETED
- Phase
- N/A
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Status
- RECRUITING
- Phase
- PHASE3
HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity
- Status
- COMPLETED
- Phase
- NA